EMBL Induced Pluripotent Stem Cells Show Potential for Finding New Regulatory Variants Two studies identified common and rare regulatory variants in iPSC lines, including those with ties to disease or differentiation. European Project Sets Out to Harness Genomics Data, AI to Create New Predictive Tools Premium Called Intervene, the project will use genomic and health data from biorepositories along with machine learning methods to develop new clinical predictive tools. New Initiative Aims to Build Organoid Cell Atlas The European project will use single-cell profiling technologies to build well-characterized in vitro models of human organs and contribute to the Human Cell Atlas. EMBL-EBI COVID-19 Data Portal to Serve as European Data Hub for Coronavirus Research Premium Launched last month as part of the EU's coronavirus action plan, the portal will collect and distribute SARS-CoV-2 sequencing and patient phenotype data. Cancer Researchers Discover Novel Inherited Mutation Predisposing Children to Medulloblastoma The researchers identified rare germline loss-of-function variants across the ELP1 gene in 14 percent of pediatric patients in a medulloblastoma subgroup. Oct 28, 2019 Study Finds Residual Protein Expression Common After CRISPR Knockout Apr 1, 2019 Colorectal Cancer Gut Microbial Signatures May Lead to New Diagnostic Tests Mar 14, 2019 EMBL European Bioinformatics Institute Awarded £45M from UK Government Mar 11, 2019 International Coalition Building Virtual Cohort of 1.4M Patients Premium Feb 12, 2019 Human Gut Metagenomic Analysis Uncovers Nearly 2,000 New Uncultured Bacterial Species Feb 4, 2019 Gut Microbe Studies Expand Bacterial Culture Collections, Reference Genomes Nov 1, 2018 Wellcome Sanger Institute, Collaborators Launch Project to Sequence 66K Species Oct 25, 2018 Amid GDPR Implementation, European Effort Drafts Code of Conduct for Sharing Health Research Data Premium Jun 21, 2018 EMBL Scientists Design New Multi-Omics Computational Method Premium Dec 5, 2017 Open Medicine Foundation Commits $1.2M to Fund ME/CFS Research Oct 2, 2017 International Team Suggests Standardized DNA Extraction Method for Fecal Microbiome Studies Aug 31, 2017 EBI Team Developing Genome Editing Resource for CRISPR Experimental Data Premium Jul 19, 2017 UK Biobank Partners With EGA to Distribute Data From Genomics Project Jun 1, 2017 UC Santa Cruz Genomics Institute Joins Human Cell Atlas Initiative May 22, 2017 Computational Model Offers Clues to Missing Heritability for Complex Human Traits May 10, 2017 Induced Pluripotent Stem Cell Variability Tallied Across Genomes Apr 11, 2017 Researchers Devise New Single-Cell DNA Methylation Prediction Method Mar 31, 2017 Age-Related Dip in Immune Cell Coordination Detected in Single-Cell Mouse Study Jul 7, 2016 Single-Cell RNA Sequencing Provides Insight Into Mouse Embryo Development Jul 7, 2016 EMBL-EBI Team Develops Method to Improve Shotgun Proteomics Identification Rates Premium Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.